← Motilal Oswal Mutual Fund

Motilal Oswal BSE Healthcare ETF

Index/ETF Data as of Apr 2026 Comparing Mar 2026 → Apr 2026
Share: WhatsApp X
Stocks Held
126
Apr 2026
Equity Holdings
₹41.80 Cr
Equity only, excl. debt & cash
Top 5 Weight
36.4%
Moderate
Top 10 Weight
55.1%
Moderate
Changes
95
0 new · 0 exits
Top Sector
Pharmaceuticals & Biotechnology
76.0% of portfolio
📋 What Happened This Month Among existing holdings, Fortis Healthcare Limited saw the biggest increase — now at 3.43% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 13.90%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 76.0%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Mar 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 74.9% 76.2% +1.3%
Healthcare Services 24.5% 23.2% -1.4%
Healthcare Equipment & Supplies 0.5% 0.5% +0.0%
Mar 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 76.2% 76.0% -0.3%
Healthcare Services 23.2% 23.4% +0.2%
Healthcare Equipment & Supplies 0.5% 0.5% +0.1%
Biggest Add
Fortis Healthcare Limited
+0.28% · now 3.43%
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.53% · now 13.90%

What Changed?

Comparing Mar 2026 → Apr 2026

Mar 2026 Apr 2026
↑ 72 Increased ↓ 23 Decreased
#StockSectorMar 2026Apr 2026Change
1
Fortis Healthcare Limited
₹1.43 Cr
Healthcare Services 3.15% 3.43% +0.28%
2
Cohance Lifesciences Limited
₹23.13 L
Pharmaceuticals & Biotechnology 0.37% 0.55% +0.18%
3
Divi's Laboratories Limited
₹2.47 Cr
Pharmaceuticals & Biotechnology 5.76% 5.90% +0.14%
4
Glenmark Pharmaceuticals Limited
₹1.07 Cr
Pharmaceuticals & Biotechnology 2.43% 2.56% +0.13%
5
Neuland Laboratories Limited
₹38.40 L
Pharmaceuticals & Biotechnology 0.79% 0.92% +0.13%
6
Laurus Labs Limited
₹1.27 Cr
Pharmaceuticals & Biotechnology 2.93% 3.04% +0.11%
7
Mankind Pharma Limited
₹74.63 L
Pharmaceuticals & Biotechnology 1.70% 1.78% +0.08%
8
Piramal Pharma Limited
₹29.51 L
Pharmaceuticals & Biotechnology 0.63% 0.71% +0.08%
9
Wockhardt Limited
₹34.45 L
Pharmaceuticals & Biotechnology 0.74% 0.82% +0.08%
10
Syngene International Limited
₹26.41 L
Healthcare Services 0.56% 0.63% +0.07%
#StockSectorMar 2026Apr 2026Change
1
Sun Pharmaceutical Industries Limited
₹5.82 Cr
Pharmaceuticals & Biotechnology 14.43% 13.90% -0.53%
2
Lupin Limited
₹1.66 Cr
Pharmaceuticals & Biotechnology 4.26% 3.97% -0.29%
3
Torrent Pharmaceuticals Limited
₹1.27 Cr
Pharmaceuticals & Biotechnology 3.26% 3.03% -0.23%
4
Apollo Hospitals Enterprise Limited
₹2.32 Cr
Healthcare Services 5.77% 5.55% -0.22%
5
IPCA Laboratories Limited
₹63.67 L
Pharmaceuticals & Biotechnology 1.70% 1.52% -0.18%
6
Max Healthcare Institute Limited
₹2.19 Cr
Healthcare Services 5.41% 5.23% -0.18%
7
Biocon Limited
₹78.17 L
Pharmaceuticals & Biotechnology 2.00% 1.87% -0.13%
8
Alkem Laboratories Limited
₹94.35 L
Pharmaceuticals & Biotechnology 2.36% 2.25% -0.11%
9
Abbott India Limited
₹38.65 L
Pharmaceuticals & Biotechnology 1.01% 0.92% -0.09%
10
JB Chemicals & Pharmaceuticals Limited
₹50.98 L
Pharmaceuticals & Biotechnology 1.31% 1.22% -0.09%

Full Portfolio

126 stocks — Apr 2026

# Stock Sector Cap Weight & Value
1
₹5.82 Cr
Pharmaceuticals & Biotechnology
13.90%
2
₹2.47 Cr
Pharmaceuticals & Biotechnology
5.90%
3
₹2.40 Cr
Pharmaceuticals & Biotechnology
5.74%
4
₹2.32 Cr
Healthcare Services
5.55%
5
₹2.21 Cr
Pharmaceuticals & Biotechnology
5.28%
6
₹2.19 Cr
Healthcare Services
5.23%
7
₹1.66 Cr
Pharmaceuticals & Biotechnology
3.97%
8
₹1.43 Cr
Healthcare Services
3.43%
9
₹1.27 Cr
Pharmaceuticals & Biotechnology
3.04%
10
₹1.27 Cr
Pharmaceuticals & Biotechnology
3.03%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Motilal Oswal Mutual Fund — Portfolio & Holdings
See all funds managed by Motilal Oswal Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.